⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
PLSE News
Pulse Biosciences, Inc Common Stock (DE)
Pulse Biosciences to Present at the 44 th Annual J.P. Morgan Healthcare Conference
businesswire.com
PLSE
Pulse Biosciences Announces FDA IDE Approval to Initiate its nPulse Cardiac Catheter Ablation System Study for the Treatment of Atrial Fibrillation
businesswire.com
PLSE
Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
businesswire.com
PLSE
Pulse Biosciences, Inc. Announces Participation in Upcoming Investor Conferences
businesswire.com
PLSE
Pulse Biosciences Reports Business Updates and Third Quarter 2025 Financial Results
businesswire.com
PLSE
Pulse Biosciences Announces First Enrollment in the NANOCLAMP AF Study
businesswire.com
PLSE
Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
businesswire.com
PLSE
Pulse Biosciences Announces Presentation of Late-Breaking Data From the nPulse™ Cardiac Surgical System First-in-Human Feasibility Study at the 39th European Association for Cardio-Thoracic Surgery Annual Meeting
businesswire.com
PLSE
Pulse Biosciences Announces Clinical Data Highlighting its nPulse™ Cardiac Surgical System to be Presented at the 39 th European Association for Cardio-Thoracic Surgery Annual Meeting
businesswire.com
PLSE
Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
businesswire.com
PLSE